GeneDx, a medical services company, outperformed the S&P 500 this year.
1 report, 1 independent
Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GeneDx, a medical services company, outperformed the S&P 500 this year.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GeneDx
company in Stamford, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksGeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Beat Estimates GeneDx Holdings Corp. (WGS) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.1 per sh